Alex Federman
Overview
Explore the profile of Alex Federman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
41
Citations
352
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Social Vulnerability and Biological Aging in New York City: An Electronic Health Records-Based Study
Knobel P, Colicino E, Kloog I, Litke R, Lane K, Federman A, et al.
J Urban Health
. 2025 Jan;
PMID: 39809980
Chronological age is not an accurate predictor of morbidity and mortality risk, as individuals' aging processes are diverse. Phenotypic age acceleration (PhenoAgeAccel) is a validated biological age measure incorporating chronological...
2.
Apter A, Barg F, Basu S, Federman A, Hamilton W, Krishnan J, et al.
Trials
. 2024 Dec;
25(1):841.
PMID: 39702510
Deviation from protocolized assessment times is commonplace in pragmatic randomized clinical trials. Working with a stakeholder advisory board for a Patient-Centered Outcomes Research Institute®-funded project on statistical methods for handling...
3.
Greenfield N, Wysocki M, Arcoleo K, Rodriguez J, Jariwala S, Busse P, et al.
J Behav Med
. 2024 Dec;
PMID: 39672992
Objective: To examine the impact of coping styles in older adults with asthma on the prospective relationship between depressive symptoms and asthma outcomes, and how their perceptions of social support...
4.
Ma T, Knobel P, Hadley M, Colicino E, Amini H, Federman A, et al.
NEJM Evid
. 2024 Nov;
3(12):EVIDoa2400182.
PMID: 39589192
Background: Fine particulate matter (PM) exposure is adversely linked to atherosclerotic cardiovascular disease (ASCVD). However, most studies focused on PM mass rather than its chemical composition and specific sources. Particulate...
5.
Anderson 3rd W, Baptist A, Eakin M, Federman A, Murphy V
J Allergy Clin Immunol Pract
. 2024 Aug;
12(12):3216-3222.
PMID: 39122111
Poor adherence to controller therapies is a universal challenge to asthma control. Several high-risk groups, including adolescents, pregnant women, and older adults, have their own unique challenges to adherence. The...
6.
Social Vulnerability and Biological Aging in New York City: An Electronic Health Records-Based Study
Knobel P, Colicino E, Klog I, Litke R, Lane K, Federman A, et al.
medRxiv
. 2024 Jul;
PMID: 38978670
Chronological age is not an accurate predictor of morbidity and mortality risk, as individuals' aging processes are diverse. Phenotypic age acceleration (PhenoAgeAccel) is a validated biological age measure incorporating chronological...
7.
Wisnivesky J, Agrawal N, Ankam J, Gonzalez A, Federman A, Markowitz S, et al.
PLoS One
. 2024 Feb;
19(2):e0297616.
PMID: 38349898
Background: Post-traumatic stress disorders (PTSD) is associated with worse asthma outcomes in individuals exposed to the World Trade Center (WTC) site. Research Question: Do WTC workers with coexisting PTSD and...
8.
Federman A, Wisnivesky J
J Allergy Clin Immunol
. 2024 Feb;
153(4):983-984.
PMID: 38316270
No abstract available.
9.
Lovett R, Filec S, Bonham M, Yoshino Benavente J, OConor R, Russell A, et al.
BMJ Open
. 2023 Oct;
13(10):e077911.
PMID: 37899164
Introduction: COVID-19 is an unprecedented public health threat in modern times, especially for older adults or those with chronic illness. Beyond the threat of infection, the pandemic may also have...
10.
Wisnivesky J, Agrawal N, Ankam J, Gonzalez A, Busse P, Lin J, et al.
Ann Allergy Asthma Immunol
. 2023 Aug;
132(1):62-68.
PMID: 37580015
Background: Post-traumatic stress disorder (PTSD) is a major risk factor for increased asthma morbidity among World Trade Center (WTC) workers. Objective: To investigate whether differences in perception of airflow limitation...